-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BO8LBWLiLngIDvAtFhUbEN7h9aCcwMb2syxmuykHIFpxYmVEbb7IE9lR9wpZaFjq ADaLhe31Uhs9VUEL+6f3SA== 0001157523-10-000112.txt : 20100112 0001157523-10-000112.hdr.sgml : 20100112 20100111193232 ACCESSION NUMBER: 0001157523-10-000112 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20100111 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100112 DATE AS OF CHANGE: 20100111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MOLINA HEALTHCARE INC CENTRAL INDEX KEY: 0001179929 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 134204626 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31719 FILM NUMBER: 10521312 BUSINESS ADDRESS: STREET 1: 200 OCEANGATE, SUITE 100 CITY: LONG BEACH STATE: CA ZIP: 90802 BUSINESS PHONE: 5624353666 MAIL ADDRESS: STREET 1: 200 OCEANGATE, SUITE 100 CITY: LONG BEACH STATE: CA ZIP: 90802 8-K 1 a6138698.htm MOLINA HEALTHCARE, INC. 8-K a6138698.htm
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 
FORM 8-K
 


Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): January 11, 2010
 
 

 
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
 
 
         
Delaware
 
1-31719
 
13-4204626
(State of incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification Number)
 
 

 
 
200 Oceangate, Suite 100, Long Beach, California 90802
(Address of principal executive offices)

Registrant’s telephone number, including area code: (562) 435-3666

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 
 Item 2.02.      Results of Operations and Financial Condition.
 
On January 11, 2010, Molina Healthcare, Inc. issued a press release announcing its preliminary unaudited financial results for the fourth quarter and year ended December 31, 2009.  The full text of the press release is included as Exhibit 99.1 to this report.  The information contained in the websites cited in the press release is not part of this report.

The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.

Item 9.01.       Financial Statements and Exhibits.
 
(d)         Exhibits:
 
Exhibit
No.
Description

99.1
Press release of Molina Healthcare, Inc. issued January 11, 2010, as to preliminary unaudited financial results for the fourth quarter and year ended December 31, 2009.
 
 

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
   
MOLINA HEALTHCARE, INC.
   
Date: January 11, 2010
 
By:    /s/ Mark L. Andrews
   
Mark L. Andrews
Chief Legal Officer, General Counsel,
   and Corporate Secretary
 
 

 
EXHIBIT INDEX
 

Exhibit
No.                  Description

99.1
Press release of Molina Healthcare, Inc. issued January 11, 2010, as to preliminary unaudited financial results for the fourth quarter and year ended December 31, 2009.

EX-99.1 2 a6138698ex99-1.htm EXHIBIT 99.1 a6138698ex99-1.htm
 
Logo 

 
News Release
 
Contact:
Juan José Orellana
Investor Relations
562-435-3666, ext. 111143


MOLINA HEALTHCARE REPORTS PRELIMINARY
FOURTH QUARTER AND 2009 YEAR-END RESULTS

Long Beach, California (January 11, 2010) – Molina Healthcare, Inc. (NYSE: MOH) announced today that, based on its preliminary unaudited analysis, it expects to report a loss per diluted share for the fourth quarter of 2009 in the range of $0.10 to $0.25, and earnings for the year ended December 31, 2009, in the range of $1.12 to $1.26.  Additional detail regarding the Company’s preliminary unaudited results is provided in the tables below.

In commenting on the preliminary results, J. Mario Molina, M.D., president and chief executive officer of Molina Healthcare, said, “In our third quarter earnings report in October, we talked about the several factors – including the H1N1 flu, higher utilization associated with new members, and state budget shortfalls – which were the basis for our withdrawing our earnings and medical cost guidance for the remainder of 2009.  These same factors continued to exert significant downward pressure on our earnings in the fourth quarter.  Of these factors, costs associated with the H1N1 flu were the single greatest contributor to our loss in the quarter.”

The Company is currently in the process of finalizing its results for the fourth quarter and full year 2009.  There can be no assurance that the Company’s final audited results for the fourth quarter and for fiscal year 2009 will be as specified in this release.  The estimated results for fourth quarter and full year 2009 included in this release constitute forward-looking statements and are subject to the risk that final audited results may vary.

The Company plans to announce its complete results for the fourth quarter and full year 2009 on February 11, 2010.  In addition, the Company will give a presentation and webcast regarding its corporate strategy and business outlook at its Investor Day Conference on January 27, 2010, at the Le Parker Meridien Hotel in New York City from 12:00 noon to 4:00 p.m. Eastern Time.  Additional information regarding the Company’s earnings call and Investor Day Conference will be forthcoming.

J. P. Morgan Healthcare Conference Presentation on Tuesday, January 12, 2010

The Company will give a presentation, followed by a question and answer session, at the 28th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2010, beginning at 3:30 p.m. Pacific Time.  To access the broadcast, listeners should go to the Investors section of the Company’s website, www.molinahealthcare.com, approximately 15 minutes prior to the event to register and download any necessary software.  For those unable to listen to the live broadcast, a replay will be available for 30 days on the Company’s website.
 
 
-MORE-

 
Fourth Quarter 2009 Preliminary Unaudited Financial Results Compared With Fourth Quarter 2008 Financial Results

 
4Q 20081
4Q 2009E
Change
Premium Revenue
$809M
$962M
$153M
Medical Care Ratio
84.7%
87.2%
2.5%
G&A Ratio
11.3%
12.3%
1.0%
Core G&A Ratio
     (excluding premium tax)
8.1%
8.2%
0.1%
Depreciation & Amortization
$8.7M
$9.6M
$0.9M
Net Income
$14.8M
($2.6M) to ($6.4M)
($17.4M) to ($21.2M)
Diluted EPS
$0.55
($0.10) to ($0.25)
($0.65) to ($0.80)
Diluted Shares Outstanding
26.8M
25.7M
(1.1M)
_____________
(1)
The Company’s 4Q 2008 results reflect the adoption of ASC Subtopic 470-20.
E
Represents preliminary unaudited estimate.  Final audited results may differ.

Full Year 2009 Preliminary Unaudited Financial Results Compared With Full Year 2008 Financial Results

 
20081
2009E
Change
Premium Revenue
$3.1B
$3.7B
$0.6B
Medical Care Ratio
84.8%
86.7%
1.9%
G&A Ratio
11.1%
10.9%
(0.2%)
Core G&A Ratio
     (excluding premium tax)
8.0%
7.6%
(0.4%)
Depreciation & Amortization
$33.7M
$38.0M
$4.3M
Net Income
$59.6M
$29M to $33M
($26.6M) to ($30.6M)
Diluted EPS
$2.15
$1.12 to $1.26
($0.89) to ($1.03)
Diluted Shares Outstanding
27.8M
26.0M
(1.8M)
_____________
(1)
The Company’s 2008 results reflect the adoption of ASC Subtopic 470-20.
E
Represents preliminary unaudited estimate.  Final audited results may differ.

About Molina Healthcare, Inc.
Molina Healthcare, Inc. is a multi-state managed care organization that arranges for the delivery of healthcare services to persons eligible for Medicaid, Medicare, and other government-sponsored programs for low-income families and individuals.  Molina Healthcare’s nine licensed health plan subsidiaries in California, Florida, Michigan, Missouri, New Mexico, Ohio, Texas, Utah, and Washington currently serve approximately 1.45 million members.  More information about Molina Healthcare can be obtained at www.molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains “forward-looking statements” regarding the Company’s expected financial results for the fourth quarter of 2009, and for the full fiscal year 2009, as will be reported by the Company upon the completion of its year-end audit.  Final financial results may vary.  For a full discussion of the risks faced by our Company, please see our Form 10-K annual report, and our other periodic reports and filings with the Securities and Exchange Commission.  These reports can be accessed under the investor relations tab of our Company website or on the SEC’s website at www.sec.gov.

-END-
GRAPHIC 3 logo.jpg LOGO begin 644 logo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_[3(`4&AO=&]S:&]P(#,N,``X0DE-!"4` M`````!``````````````````````.$))30/J`````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`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`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``#```` M2`!(``````+>`D#_[O_N`P8"4@-G!2@#_``"````2`!(``````+8`B@``0`` M`&0````!``,#`P````%__P`!``$```````````````!H"``9`9```````"`` M`````````````````````````````````#A"24T#[0``````$`!X`````0`! M`'@````!``$X0DE-!"8```````X`````````````/X```#A"24T$#0`````` M!````!XX0DE-!!D```````0````>.$))30/S```````)```````````!`#A" M24T$"@```````0``.$))32<0```````*``$``````````3A"24T#]0`````` M2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H`!@```````0`R`````0!: M````!@```````0`U`````0`M````!@```````3A"24T#^```````<```____ M_________________________P/H`````/__________________________ M__\#Z`````#_____________________________`^@`````____________ M_________________P/H```X0DE-!`@``````!`````!```"0````D`````` M.$))300>```````$`````#A"24T$&@`````#2P````8``````````````5`` M``/\````"P!M`&\`;`!I`&X`80`@`&P`;P!G`&\````!```````````````` M``````````$``````````````_P```%0``````````````````````$````` M````````````````````$`````$```````!N=6QL`````@````9B;W5N9'-/ M8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG``````````!,969T M;&]N9P``````````0G1O;6QO;F<```%0`````%)G:'1L;VYG```#_`````9S M;&EC97-6;$QS`````4]B:F,````!```````%7!E96YU;0`` M``I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S3V)J8P````$```````!2 M8W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<``````````$)T M;VUL;VYG```!4`````!29VAT;&]N9P```_P````#=7)L5$585`````$````` M``!N=6QL5$585`````$```````!-'14 M15A4`````0``````"6AOD%L:6=N M````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0````]%4VQI8V5697)T06QI M9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N=6T````115-L:6-E0D=# M;VQO7U5F9VAI:F MML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1! M46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD23 M5*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V M)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/54DDDE-/JG5<3I6+]IRB=I(:QC M1+G..NU@]O@LSI7UQP.H93<5];\:RPQ47D%KCV9N;]&QWYBJ?7S$OMQL7*K: M758[GBV-=H>&;;#_`"&^GM_MKE>D8M^;U+'HQ@2_U&O21^K4&S)LO;D6LKMJ>9:18X,/ILT;4YN[7!'U/6]>?U?&Q;,SIUK(I:7VT6,#I:WW/ M?6^6>YK?S'?37(4?6_JU!/I,QF@F7-;5M!/\K8]JZ6GZQX76.F9U=0=5D5X] MCG4OB=NTC>QS?:]FXKS\<#X*3!C!$HSB+!:WQ'F91ECR8,IX9@G0^G_T%['# M^M/4>J1C8VS&ZB&N=6PMWTW;1O=6-Q;9CV[?H>^RM9%7UMZK4]UE;,9CWZO< M*0TN_KEKMRK?5[_EW!_XT?DI=>Z!T3)8 M+<3+.;9D-/8,QGT5N'[KVNR]U;_S'JMS..,".'2W3^%\SDS0F,AXC`BI=:D[ MO1NJ8_6.EXO4\;^:RJQ8&S):3_.5.C\^FS=59_+7,_5_ZZY'6OKKU#I51K/2 ML>FPXS@/>]]+Z*++/5#W-?6]]E_I^W^:]-/4;4&0V_T,=KF>H^F MQ]=/Z3Z>1^B_FV?:%'KF7]=?JKA?M9V=5UW"J_UC)_?]>BQ=?\`7[+IQ?JA MU1UT?I:'45M[FR[]!4&_VW[DE-'ZP_7&QGU-I^L?0W-'K65@-O9,;G^A=38S ML?\0__`*G`5YWU?POK/D?6;!R7 M%CF9U;L;(;JZJUN+CU>HUOY[';=EU7^%K_[<24[GUSZQE]'^J^;U7`+/M%`K M=47C,6W9+0^ZW'KJ=<_TJF/LM]_Z6M)2#_%_P#7#J'U MAQNH59X8.H8KQ956`&#TK`?3JV3N_075V5V/_P"*70=!OZM=B/=U6OT[A8X- M]H9+`3L.T.?^9L_M[Z_\'Z]WGV3F9'U?_P`8^/UC(P[NFX?6/T5[+S29W^G1 M?8+,6W(K].K(;AY-FZSU/YU>J)*?_]'U5>39G],R/^.L_P"K7D'(^-?)B\Y-[H']+O_P#"F1_U"S!P/@M+H#F_:\C4?T3( M[_\`!K,#FP-1QXJR/FEY!RI_S./SG_W+I?5[_ES!_P"-'Y'*@[Z;OZQ_*KWU M>W<[W#Z1[^:0^<^0_P"Z5+^8A_?G_P!'&DQOZ33_`,8S M_JFKOLFGHS_K?AVW9;QU>K$L&-A2/3-3W'U;_P";W>I[=G\__@_YM>?X[V_: M:=1_.,[_`,IJZ;K=63D?XQ\&C$S3@7GI=A%K65VNCU7>WT[PYGNV_2_D*MS> M\?JZOP7YCXWHYPCV5,(=>,E_Z/>Z_P"SLMJ] M5EO]'_1*E3A_53ZR_6BCKF#GWOZAA5L>UE0V4NK:;&!SO7Q_TF_UK*G>E>LS MI[;*KD.8RLNC%O^E53%;=GT/["N?4WK.+A_5VK)R>MT9> M/A=-KLLZ?4VH74"MK?4W^E:ZY[O\!ML8S])_PBJNNZ'4OJ[]7>N==MR<;)MP MNO\`3/3]?)PW>G:WU&.^SMR-[+*;O4H]OT=_H?H?YKV*M_S:Z7UOJMF-UGJ^ M3UJ_I)8ZW`L#*:&&UKGT/NIQ*<=MSW5_\)]#]'9[%D=.;U3ZO?6;IO5NK4?9 MF_6`/Q>HO]4V-^U6N=F8GLVCT?2W?8*F^I:QF/7_`-/1:T MMW8]%M;<>IME+ZF_0:]/CV`_XT#_P!_5+IV'U'+^O/UI^P= M1=T\L=@>ILJKMWS0[:/UAK]GI[7_`$/WTE-_HW2_JP_JN7]=,'J%EHM]5N19 M8YC<=H`8+OITU6,;5Z#/>ZY%^KV=]6J^I9/V#,OMR.N6ORZQD5V5UV&L;;?V M?;9CX]61577_`*.W(]BXNNK(R?\`%>3CM=E44]2=;U"NH2Y^.RYUEOLK_P"L MW?R*_P!(O1J/K)]7+JJ[*.HXSV.K=:S;8V176TOMLYS/I6,MK=3995[Z_^+0LK-^J_2OK1 ME=3SL]XZD<6NE]3VEU=&-N:YI;Z-/Z*NW(]]EM]W\[9^8N9^UYG3.K=*^NN7 MC_9\7JU[ZLW(=:"3BY89^RFW5-;LQZ\#&Q\=]WO]]O\`QB7UPORZ_K-UPXL6 M5CI5+>H4M$W'#=9LSW8CC-=5]5-N_?=797Z7O24]!]>,;ZH=6Q,"KK>:ZAMI M=;@78WO?8W:UMK:BVG*;94]EU-GM9_HUT72;\?(Z9BVXU[\NAU30S)M!#[`T M;/5MW-J_2/V^_P#1L7#]=R>F4YOU*LZ9U&K"Z>RK*;BY]NUS&UMQZJF>K]H= M4S>[^9?ZOO\`5_X5=QTFPV].H>G.D3VX3?HOY/X+Y8225 M]C]3_HOY/X)SZ>\3&^-.)A?*Z2"@_4_Z+W_1_P"$X_Z:A^J2[^;G\[CQ_._M M+Y;222_4]GI[?TFW;/YT1/S47?9MWOV;I[Q,Z+Y:224_5'Z/?VWQY3"0V;G; M8W:;HY\MR^5TDE/U0ST]OZ.-O\F(_!5J?V7ZE_H>AZFOVG9LW=Y]?;_Z,7S` MDDI^J'^GL/J1L[[HC\4WZ+`````$```!X`````0```$%D;V)E(%!H;W1O)E\K.$P]-UX_-&)Y2DA;25 MQ-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0% M!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C M+RLX3#TW7C\T:4I(6TE<34Y/2E MM<75Y?569G:&EJ:VQM;F]B7I[?'_]H`#`,!``(1`Q$`/P#U5))) M)33ZIU7$Z5B_:_\`5;])[TL.&$X&4CK_`-%//<[GPYXPQQ'"0#MQ>Y?1]<24:VEM;6N=N+0` M7'DD?G*2K.HI))))2DDDDE*22224I))))2DDDDE*22224__0]*ZKE68?3W&>:*6Y+X/Z%[M@<(U9OV6-]W\OV+A,3KO2,'*^TT=&].]I(&Z] MQV'Z+ME=E;FUN5C`+C,<'$3_`'?VN;\0EPY<,CF]F(-D5D]7EP1]3UO7G]7Q ML6S,Z=:R*6E]M%C`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`K?U3J7UF/U8^K+:FOHW? M;^I7CU&U!D-O]#':YGJ/IL?73^D^GD?HOYMGVA1ZYE_77ZJX7[6=G5==PJG- M&91;0W&L8QQ:SU*+<4[?I._PE5OH_P`Y^E6+_BS:<3ZX==PLO^F@6>YW)V7O M]8R?W_7HL77_`%^RZ<7ZH=4=='Z6AU%;>YLN_05!O]M^Y)31^L/UQL9]3:?K M'T-S1ZUE8#;V3&Y_H74V,W,_256>QVU_YBW/JYFY'4.@=/SLH@WY6/7=86B! MN>T6>UO]I>9NQ^\$#)SFWTAP(/INM:UCH=^;9L]5G\BQ>C?4[_Q) M]'_\)8__`)[8DIQ>E_6?K&5]?\_ZOW.J^PXK++&0R'Z#'+`ZS=]7\+ZSY'UFPQVW9=5_A:_^W$E. MY]<^L9?1_JOF]5P"S[10*W5%XW-AUE=;O;+=WZ-ZU&#J&*\655@!@]*P'TZMD[OT%U=E=C_\` MBET'0;^K78CW=5K].X6.#?:&2P$[#M#G_F;/[>^O_!^O=Y]DYF1]7_\`&/C] M8R,.[IN'UC]%>R\TF=_IT7V"S%MR*_3JR&X>39NL]3^=7JB2G__1]57DV9_3 M,C_CK/\`JW+UE>2YCF_;,C4?SUG?^6Y6N4WEY!R/C7R8O.3>Z!_2[_\`PID? M]0LP<#X+2Z`YOVO(U']$R.__``:S`YL#4<>*LCYI>0_Y< MP?\`C1^1RH.^F[^L?RJ]]7G-_;N#J/YT?D_FD/G/D/\`NE2_ MF(?WY_\`1QI,;^DT_P#&,_ZIJ[[)IZ,_ZWX=MV6\=7JQ+!C84CTS4]Q]6_\` MF]WJ>W9_/_X/^;7G^.]OVFG4?SC._P#*:NFZW5DY'^,?!HQ,TX%YZ781:UE= MKH]5WM].\.9[MOTOY"KVRG(^OS,G)^UVUX]7JY#F,K+HQ;_I54Q6W9]# M^PKGU-ZSBX?U=JR[_`;;&,_2?\(J MKKNAU+ZN_5WKG7;RRF[U*/;]'?Z'Z M'^:]BK?\VNE];ZK9C=9ZOD]:OZ26.MP+`RFAAM:Y]#[J<2G';<]U?_"?0_1V M>Q9'3F]4^KWUFZ;U;JU'V9OU@#\7J+_5-C?M5KG9F)[-H]'TMWV"IOJ6L9CU M_P#7+-/I'4^FX7U^^M->9ET8S\@].;0VZQM9L<*'-M['Z.:S']MN-8VNCU75MW^GZ?\M$Z-]7.G4=1 M^QX77^JW6=$-(MP'7CT6M+=V/1;6W'J;92^IOT&O3X]@/^-'*9NDCH[/;/$7 M@_\`?U2Z=A]1R_KS]:?L'47=/+'8'J;*J[=\T.VC]8:_9Z>U_P!#]])3?Z-T MOZL/ZKE_73!ZA9:+?5;D66.8W':`&"[Z=-5C&U>@SWNN1?J]G?5JOJ63]@S+ M[^O_BT+*S?JOTKZT974\[/>.I'%KI?4]I=71C;FN:6^C3^BKMR/?9;? M=_.V?F+F?M>9TSJW2OKKEX_V?%ZM>^K-R'6@DXN6&?LIMU36[,>O`QL?'?=[ M_?;_`,8E]<+\NOZS=<.+%E8Z52WJ%+1-QPW6;,]V(XS75?53;OWW5V5^E[TE M/0?7C&^J'5L3`JZWFNH;:76X%V-[WV-VM;:VHMIRFV5/9=39[6?Z-=%TF_'R M.F8MN->_+H=4T,R;00^P-&SU;=S:OTC]OO\`T;%P_7JIGJ_:'5,WN_F7^K[_`%?^%7<=)L-O3J'G,KZD2W7-J#0R MT@P;&-I=96W^P])3_]+U50_1_P`G\%\L))(+]4#T^T?@F_1?R?P7RPDBK['Z MH'ISI$]N$WZ+^3^"^6$DE?8_4_Z+^3^"<^GO$QOC3B87RND@H/U/^B]_T?\` MA./^FH?JDN_FY_.X\?SO[2^6TDDOU/9Z>W])MVS^=$3\U%WV;=[]FZ>\3.B^ M6DDE/U1^CW]M\>4PD-FYVV-VFZ.?+IK]IV;-W>?7V_^C%\P))*?JA_I[#ZD;.^Z(_%-^BW'Z.Z->)CS7RPDDI^ MI?U;:/H;-8XCGW_])39LVCTXV=MO'X+Y7224_P#_V?_;`$,`"`8&!P8%"`<' M!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H<'"`D+B<@(BPC'!PH-RDL,#$T-#0? M)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,O_``!$(`&P!1P,! M(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_Q`"U M$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C0K'! M%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_ MQ``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($!`,$ M!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K" MP\3%QL?(RKR\_3U]O?X^?K_V@`,`P$``A$# M$0`_`/?Z***`"BBB@`HHKB_&GC-M$<:?I^QKUEW/(W(A!Z<=V[\^W7-7"$IR MY8F.(Q%/#TW4J/0[2BO!I/$FN22F1M7OMQ.?EG91^0.*[+PAX\N)[V+3=8<2 M>:0D-Q@`ANRMCKGIGUZYSD;SPDXQON>;A\ZH5:B@TU<]'HHK*\0:[;^'M+>\ MG4NQ.R*('!=CT&>PZDGVKF2,=>U&8NVH2P+GY8 M[9C&%]N.3^)-7-%\>ZOIDZBZF>]M<_.DIRX'JK=<_7(_G74\'-*YY$<]P[GR MM-+N>R45!9W<%_9PW=LX>&50Z,.X-3UR;'LIIJZ"BBB@84444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`5X+XBFDG\2ZH\A);[5(O/4`,0!^``'X5[U7DGC_`,.S:?JTNJ0QDV=R MVYF`_P!7(>H/U/.?4D5V8.24VGU/$SRE.=!2CLGJ<;1DKR"01R".U%;7AGP_ M/X@U5(51OLJ,&N).RKZ9]3T'Y]J]*4E%79\M2IRJS4(*[9[99RO/8V\T@P[Q MJS#T)&:\V^*4SMJEA`?]6D+./J6P?_017J```P!@"N/^('AZ;5]-BN[1#)O(P\E&JFS[/,Z4ZF$E&.KT^=CR*BBI+>WFN[B.WMXF MEFD.U$49)->P?$I-NR/6/AI-)+X6=')*PW+HGL,*W\V-=C61X:T<:%H5O9$@ MR@%Y6'0N>3^73Z"M>O$JR4IMH^^P=.5/#PA/=(****S.D****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"H;JZA MLK26ZN9!'#$I=V/8"IJY/XC&4>$9?+SL,T8DQ_=S_CMJZ<>:2CW,<15=*E*H MELKG-7_Q0OWN6_L^SMXX`?E\\%G(]3@@#Z<_6NB\*>.(]>G%E=PK;WN"5V'Y M)<0<=N>G6O(:TO#QD'B72S%G?]JCZ>FX9_3->E4PU/D=D?*8;-<3[9.4 MKIO8]UN;A;6$RLDKJ.HBC+M^0Y/X5STOCOPRP>&:ZUN4MXE^ZBVSJO_H->.T5Z#PL9 M:.3/F89Q4IN\*<5Z+_@GT%9:I8:DA:RO(+C`R1&X)'U';\:S+[QAH^FS^1?2 MW%O+U"R6T@S[@[<$>XKQ.*62"5989'CE0Y5T8JRGV(KT3PWKD'BZU?0-?19I M]I:"?`#-C^3CKD=1G/?///"J'O/5'I8?.)8C]VDHSZ7U3\O+\2?4-6^'^J3F M:[56E/+.D$J%OJ5`S^-6-,\1^!]'S]@98"W!?[/(6(]"Q!.*\UU;3I=(U:YL M)3EX'V[L8W#J#^((/XU3KH6&C*/Q.WJ><\UJTZC;IQ4EY:_F>[6/BC1-18); M:G`SDX".VQC]`V":UZ^Z'<1P7,CSZ<3AHV.3&/5?IZ=/IUK"I@ MK*\&=^&SU2DHUHV\T>S5FZ[K^F^&M+?4M6N#!:(RHSA&?!8X'"@D_E6@CK+& MLB,&1@&5@<@@]Z\L^/MUY7@FQMP>9]03(]55'/\`/;7"?0H]!T#Q#I?B?3!J M.D7/VBU+M'NV,A#*>00P!'8\CH16I7SK\#/%']F>)9]!N),6VIC=#D\+.H_3 M M4].0926 M%PZ,/4$<&B[NHK&RGNYB1%!&TK[1D[5&3@=^E?*O@7QKJ/@+7\2^:-/:79?V M1[8.&8#LZX_'&#V(^G]6>.X\.7SHRR126DA5@\$7<\$%O MJ\DDT\BQQQBRG!+,0`,E,=3ZUW%?&OA!!)XP\/(V<-J5J#C_`*ZI7V50`5P/ M_"Z/`?D>9_;$N<9V?8I\_P#H&/UKOJ^)DBQ?+"3C]\$)'^]B@:/MFN3L?B7X M2U'7$T:WU7_3WE:$1R02(-ZG!72F_[VW;C:<]:Z*O#9HMW[4L.<$$A_P`K(_U% M>Y4`07MY!I]A<7MRX2WMXFEE<_PJH))_(5@^%?'FA>,I+J/1YY7>V5&D66(Q MD!LXQGKC:T2ZU&!Y-/U.[LKL#Y=DS>6Q]&7M]1^O2JCOO8SJMJ#M&_D<%?_``TU:&X( ML98+F`GY69MC`>XZ?D?RKI/"/@;^Q+H:AJ$L?\`?XUZ4J=:4>5R1\I2 MQ.!HU?:*F[KSV/>*KWX!TZY!&08F_D:\GTSXB:U92*+MH[V'NLBA6Q[,!_,& MO2K;5[36_#TM[9ONC:)PRG[R-CE2/6N*I0G3:N>_A\PHXJ+4'KV9X..@I:0? M='TI:]@^'"M?PK(T7BO2V0X)N%7\#P?T)K(K5\,_\C3I?_7RG\ZFI\#-L-_& MAZK\S1\?@#QE>8'58\_]\"N9KIO'_P#R.5Y_NQ_^@"N9J:/\./H:8[_>:GJ_ MS"BBBM#E/<_"4C2^$],9CDB!5_`<#]!7G/QB6+5/%_@C0Y07AN+S]^@.,HTD M2=?IOKT3P=_R*&F?]'4^-GZ%A MM:,/1?D>3>(=(O?!GC"YL%E9+BPN!);3]R`0T;^F<;3]*?#% MCK$&%^T1_O$!_P!7(.'7\&!_#!KS?X\^%_M6DVOB6WC_`'MF1!=$=3$Q^4_\ M!7J2CRY`?]0Q^60CW9./8@&H-SLM0B;X MJ>-?$FJ(=^CZ-ITT5H<_*[['$9'U?=)GT50:XWX9W8L_B3X?G];GR_\`OXC) M_P"S5]"?#CPDOACP+;Z?<1[;NZ4SW@[AW`^7_@*X7\/>OF#0;@Z9X@TFZ02-_P"12?Y4`>W?M!WLD>AZ+8*2(Y[IY6]]BX`_P#'_P!*YKX!6J2^,M1N M6`+06)5<]MSKD_\`COZUV/Q[TJ2[\(66I1H6^PW0\PC^&.0;<_\`?6P?C7#_ M``(U&.T\=3V?!BPDD.2NF/#^"!D'Z** M^;O$&HG7_%.I:A`CO]MO)'A0+\S*S'8N/7&T8]:^I-+T=O#_`,-8=*DQYMMI MI27!R#)L)?'MN)H&SY>\&_\`(Y^'/^PG:?\`HU*^R*^-_!O_`".?AS_L)VG_ M`*-2OLB@&%?%0_Y"X_Z^?_9Z^U:^*A_R%Q_U\_\`L]`(^U:\"\%^&]/\8^)_ MB%INI1_))>%XY%^_"_G3893ZC]1D'@U[[7B?P2D\[QCXRER3OE5LDYZRRF@1 MY/X@T#5_!/B,V5TSPW5NPEM[F$E0X!^61#VY'X$8KZ#^&/Q'B\96'V&_9(]; MMDS*HX$ZCCS%'\QV/L16[XU\&Z?XUT-K&\'ESIE[6Z5A7N/0@$?+ M=Y::UX*\3F&0O9:K82!DDC/Y,I(^92/4<@D$=10/<]@"%_VH"1CY(-Q_\!L? MUKVBOGGP%XBE\5_&VUUB:!89IK1EE1#E=RPA21Z`D9QVSC)ZU[!X_P#$@\*^ M"]0U)&`N=GE6H/>5^%X[X^\1Z*:!'FL9_P"%@_'W?_K-+T#IZ$Q-^63*<^ZI M7GGQ,\/_`/".^/=2M(U*6]PWVNWQQ\DF20/8-O4?[M=9\.="^(FEZ.=1\-VN MFI;:F%D,MZV7=5W!>,Y`Y)'KG-5?B5HGCRZL8]<\4VFG"&R_<^=9D9P[`#<, M\C=C'IN]Z!GMW@/Q#_PE'@O3=49@;AXO+N/:5?E?CMDC(]B*Z.O`_@'XC^S: MI?\`AR=\)=+]JMP3_P`M%`#@>Y7:?^`&O?*!!1110`4444`>%^+./%FI_P#7 M@?#AV.F:]&6.Q8T8#T)5 M\G]!^5>?UWWPW_X\/$'_`%RC_E)6>)_A/Y?F=65?[W'Y_DS@!]T?2EI!]T?2 MEK<\X*U?#/\`R-.E_P#7RG\ZRJU?#/\`R-.E_P#7RG\ZF?PLVP_\:'JOS-'Q M_P#\CE>?[L?_`*`*YFNF\?\`_(Y7G^['_P"@"N9J:/\`#CZ&F._WFIZO\PHH MHK0Y3W'P=_R*&F?]%@C".%H1AL8/2O M6O!W_(H:9_UR_J:BLO'/AO4?$+Z#:ZD)-3222)H!#("&3.\9*XXP>]>'4^-^ MI^@X7^!#T7Y&QJ%C;ZGIUS87<8DMKF)HI4/\2L,$?K7SMX&^'-W_`,+4DTW4 MX7:TT67SY9&3"S8(,6.WS95L>@85]":OJ]AH.ES:GJ<_D6<.WS)-K-MRP4<* M">I%0Z#XCTGQ/8O>Z/=BZMDD,3.$9<.`"1A@#T85!N:E?'6M^']576-6CBTN M_>*.[G0.ELY7`=AG('I7TOJ'Q/\`!NE7]Q8WNM+#*/S'41.N%SC/S*.YH`O0);^(_#$(OK<26^H6BF:%P1E M70$@]QU^HKY^\2_"WQ-X+UE-4\/+W7?/"0<@.@'S>F0"".H&<5 M]*5D>'O%&C>*K26ZT6^6[AAD\IV",N&P#T8`XP1ST_*@#S#2_P!H'3HK<0^( M=(N[>^08?[*%*L?7:[*R_3GZU@^*OBAK/Q`MI-"\)Z/>K:3?).T:^9-*I_A. MW(13WY.1QD#.??[DP)`\MPJF.-2Y)7=@`<\5B>'?&?ASQ1)-!H>H+=-`@=U6 M)TVJ>!]Y1Z4`<#\,_A$^AW<6N>(A&U_'S;6:D.L!_OL1PSCMC@=U-]I;;:2G`ZGY#57Q#XMT+PHEN^MWZVBW!81$QNVXKC/W0?45A?\`"WO` M>,_V_'CU^SS?_$4`?-^B66LZ;JVG:E%HFH3_`&*YBGV"VD` MN3?&CQ0%+)X$N(@!R9/.('_D,5ZKX?\`$VC^*;.6[T6\%W;Q2>4[B-E`?`./ MF`[,/SJGH/COPUXFOWL='U-;JY2(RL@BD7"`@$Y90.K#\Z!AX&UZ^\2^$K75 M=1MDM;J5Y0\"*R[-LC*.&YY`!_&OE!-*U9=MU_96H!`P;?\`97QU]<8KZ^UW MQ!I?AK3Q?:O="VMC((Q(49OF.<#"@GL:DT;6M/\`$&EQ:EI=Q]HLY2P24(R[ MMK%3PP!Z@C\*!%XD`9[=:\,^`MO>V^MZXUW97,`N+>*16FB9-WS-TR!G[U>O M:[XFT7PS;+/K.HP6:/G8'.6?'7:HRS8SV%XAN[:*YMI4F M@F021R(V5=2,@@CJ"*S-0\4:+I>M6.CWM\D.H7W_`![PE6)?G'4#`R>!DC/: M@#P?X0:/JFF_$R,7VG7=MY<,\3M+"P4,``1NQ@_@:W/C+-J?B;Q5I7A?3[:Y M-M%(@EF6)C&)Y2%7)QCY4.<_[9]*]SKG=>\=^&O#%^ECK&IK:W+Q"94,4C90 MD@'*J1U4_E0,V[*TAT^QM[*V39!;Q+%&O]U5&`/R%4_$.CQ>(/#NHZ3*0%NX M'B#$9VL1\K?@<'\*Q=-^)O@S5[Z.SLM?MWN)6"(KJ\>YCT4%@!D]AU-=%J>I M6FCZ;/J%_-Y-K;KOEDVEMH]<`$T"/D?18?$&@:W::M;Z1?\`GV$X<@6[X)4X M9"0.A&5/L:^N[&\BU&PM[V#=Y-Q&LJ;EVG##(R#T/M7('XO>`P<'Q!&/^W>; M_P"(KJM(U>QUW2X-2TRX%Q9S@F.4*5W8)!X(!Z@T`7:***`"BBB@#POQ;_R- MFI_]=S_2L:MGQ;_R-FI_]=S_`$K&KW*?P+T/S[%?QY^K_,*[[X;_`/'AX@_Z MY1_RDK@:[[X;_P#'AX@_ZY1_RDK/$_PG\OS.G*O][C\_R9P`^Z/I2T@^Z/I2 MUN>>%:OAG_D:=+_Z^4_G656KX9_Y&G2_^OE/YU,_A9MA_P"-#U7YFCX__P"1 MRO/]V/\`]`%/_\`DLZ9X>^.NL:CJURMM:1WEZ#(58@,SL!PH)[FO=O! MW_(H:9_UR_J:\4\(V]M=_M!:O#=0Q31-=WWR2H&!(9NQKPZGQOU/T+"_P(>B M_(ZGXA_$?P?KW@/5=,T_68[B[F1/*B$4@W$.K=2H':KWP&`_X0"?CKJ$N?\` MOE*O_%'2-*L_AMK4\.G6<,BQH%D2!5()D4<$#WJA\!O^1`G_`.PA+_Z"E0;G M!?:-,T[]HF[N=5GMX;"*[F:5[DC8"T#8SGC[S#'X5[1XHZ>U>06,-K?\`[2=S!'PM&"9KB'SD^T2=?E!&2`..>"AKB_BEH?B3P[KNF>*+[4 M+2ZNWD54N+:V,(62+#)N7)R3SWZ)0!]$W:>993IG&Z-AGTR*\*_9TYO->/\` MT[VW\Y*]ETW6[?6_"L&M6P__P"O>V_G M)0(]RN].L;\QF\L[>Y,>2GG1*^W/7&1Q7@FGVT#?M+O;F"(P?:9AY90;?^/5 MCTZ=:^@E='SL96P<'!S@UX!ISK_PT\YSQ]KF7\?LK#^=`'O-I86=@CI9VD%L MKMN80QA`QQC)QU.`*^;/A3XCTCPQXUU*]UF]6TMWMI(E=D9LL94.,*#V4U]- MU\Y_!2TMKWQ[JT-W:P7$?V.1@LT8<`B5!D9^IH&;WQ7\?>%O$O@IK#2=5CNK MO[3'((Q$ZG`)RNQ^$?]G?YD!+8BCQ_<4;CCN1SG)S[_J.E6&KZ9+IM_:17%G*NQX77C'M MZ$=B.1VKP#X2:C_PA/Q!U#0-<(M);A!:LTG`$R-E.3V8,V#WROK7T1++'!$\ MLLBQQHI9WM MMKX`^(_.L=0\.3L=\!^UVZMUV,0'7'8!L'ZR&L7XWB-OB7HRRA6C-G"'5NA7 MSWSGVH&3?'7['K'B71=-TF-+S6?+ECFBMP&D()7RU;'?AS@]`2>`:],\96\\ M7PBU6"]D\VYBTEA+)G.YU3D_F,UY%!))\&_BQ)$ZM_8EUUQSFV<\-[M&PQZD M*?[PKV7X@S1/\--?E217CDT^0HZG(8%>"".QR*`/+/A#K7A'3/"VH1>(KO38 M[A[XLD=V%9BGEH`0"#QG=^M>V:)3_` M_0]'U7P;J,FI:797CIJ3`-BM%5J+[3.9X/#MW<%]R.8_X5]X;_Y\I/\`O^_^-:.E M^&]+T:.YCL8&C6Y4+*#(S9`SCJ>/O&M:BDZDVK-LJ&%H0?-&"3]$&_\`GRD_[_O_`(UT]%/VU3^9D_4L-_S[7W(YC_A7 MWAO_`)\I/^_[_P"-36G@C0+*[ANH+1UFA<.A,SG!'3@FNAHH]K4_F8+!X=.Z M@ON1A:CX/T75KZ2]O+9Y)Y,!F$SKT&!P#CM57_A7WAO_`)\I/^_[_P"-=/10 MJLTK)L&_^?*3_`+_O_C73 MT4>VJ?S,7U+#?\^U]R*]C90:=916=LA2"(;44L3@?4US^G_#WP[IGB9_$5K: MS)J@KJ**S;OJ="22LC.US1+'Q'H\^E:E&\EG/M\ MQ$&_"^E>$].DL-'A>&VDF,Q1Y6D^8@`\L2>BBMBB@9Q&I? M"7P?J^I76H7VGSRW-S(997^URJ"Q]@P`J_X9^'OAOPAJ$U[HMG);S31>4Y:= MY`5R#_$3W`KJ**`,;0/"^E^&OMITZ*19+V8SW,DLK2/(YZDECZY/U)I_B+PU MI?BK3!IVKVYFMA(LH"N4(89P0001P2/QK6HH`Q]%\,:;X?T-]&TY9H[%BY$; M3,Y3=]X*221SD_4FN6'P3\";0#I4YP,"VDF,Q1I&?YB`#RQ)Z**H1?#WP[#XJ_P"$F2UF&K>X>0,I*L>&)&(_ M#6E^*]-73]7A>6V642[$D9"6`('*D'O4N@Z%8>&]'ATK3(WCLX2QC1Y"Y7LDZ+M2XC8I(H]-PZCD\'(YZ5AK\'O#311 MV]YV6[,^E2"2S59&5( MV!4@[0<'[J]<]*VZ**`.4TSX<^&]'\1'7K"UFAU`R22%Q*M5CU+5K266ZBB6%'2X=`JJS,.%(!Y8]:ZBB@#`\3^"]"\8) M:KK5HT_V9F,125HR-PY&5(.#@'\!3U\)Z6OA,^&=L[:68S"(VG8L(\YVAR=V M!T'/`XK3R36C10`4444`?__9 ` end
-----END PRIVACY-ENHANCED MESSAGE-----